207 related articles for article (PubMed ID: 32769069)
1. Blockade of RANKL/RANK signaling pathway by epigallocatechin gallate alleviates mast cell-mediated inflammatory reactions.
Kim HY; Kang HG; Nam SY; Kim HM; Jeong HJ
Int Immunopharmacol; 2020 Nov; 88():106872. PubMed ID: 32769069
[TBL] [Abstract][Full Text] [Related]
2. Epigallocatechin-3-O-gallate inhibits the production of thymic stromal lymphopoietin by the blockade of caspase-1/NF-κB pathway in mast cells.
Moon PD; Choi IH; Kim HM
Amino Acids; 2012 Jun; 42(6):2513-9. PubMed ID: 21833768
[TBL] [Abstract][Full Text] [Related]
3. Epigallocatechin-3-gallate inhibits osteoclastogenesis by down-regulating c-Fos expression and suppressing the nuclear factor-kappaB signal.
Lee JH; Jin H; Shim HE; Kim HN; Ha H; Lee ZH
Mol Pharmacol; 2010 Jan; 77(1):17-25. PubMed ID: 19828731
[TBL] [Abstract][Full Text] [Related]
4. Hydrogen sulfide diminishes the levels of thymic stromal lymphopoietin in activated mast cells.
Han NR; Moon PD; Jeong HJ; Kim HM
Arch Dermatol Res; 2016 Mar; 308(2):103-13. PubMed ID: 26791024
[TBL] [Abstract][Full Text] [Related]
5. Cysteine ameliorates allergic inflammatory reactions by suppressing thymic stromal lymphopoietin production in activated human mast cells.
Nam SY; Kim HM; Jeong HJ
Nutr Res; 2018 Jan; 49():79-87. PubMed ID: 29420995
[TBL] [Abstract][Full Text] [Related]
6. Oxidation derivative of (-)-epigallocatechin-3-gallate (EGCG) inhibits RANKL-induced osteoclastogenesis by suppressing RANK signaling pathways in RAW 264.7 cells.
Xu H; Liu T; Li J; Xu J; Chen F; Hu L; Zhang B; Zi C; Wang X; Sheng J
Biomed Pharmacother; 2019 Oct; 118():109237. PubMed ID: 31376653
[TBL] [Abstract][Full Text] [Related]
7. Epigallocatechin-3-gallate suppresses the global interleukin-1beta-induced inflammatory response in human chondrocytes.
Akhtar N; Haqqi TM
Arthritis Res Ther; 2011 Jun; 13(3):R93. PubMed ID: 21682898
[TBL] [Abstract][Full Text] [Related]
8. Hyperoside regulates the level of thymic stromal lymphopoietin through intracellular calcium signalling.
Han NR; Go JH; Kim HM; Jeong HJ
Phytother Res; 2014 Jul; 28(7):1077-81. PubMed ID: 24338918
[TBL] [Abstract][Full Text] [Related]
9. Chloroquine attenuates thymic stromal lymphopoietin production via suppressing caspase-1 signaling in mast cells.
Han NR; Ko SG; Moon PD; Park HJ
Biomed Pharmacother; 2021 Sep; 141():111835. PubMed ID: 34146852
[TBL] [Abstract][Full Text] [Related]
10. (-)-Epigallocatechin-3-gallate inhibits osteoclastogenesis by blocking RANKL-RANK interaction and suppressing NF-κB and MAPK signaling pathways.
Xu H; Liu T; Jia Y; Li J; Jiang L; Hu C; Wang X; Sheng J
Int Immunopharmacol; 2021 Jun; 95():107464. PubMed ID: 33677256
[TBL] [Abstract][Full Text] [Related]
11. Cordycepin Suppresses Thymic Stromal Lymphopoietin Expression via Blocking Caspase-1 and Receptor-Interacting Protein 2 Signaling Pathways in Mast Cells.
Yoou MS; Jin MH; Lee SY; Lee SH; Kim B; Roh SS; Choi IH; Lee MS; Kim HM; Jeong HJ
Biol Pharm Bull; 2016; 39(1):90-6. PubMed ID: 26725432
[TBL] [Abstract][Full Text] [Related]
12. An osteoclastogenesis system, the RANKL/RANK signalling pathway, contributes to aggravated allergic inflammation.
Nam SY; Kim HY; Min JY; Kim HM; Jeong HJ
Br J Pharmacol; 2019 Jun; 176(11):1664-1679. PubMed ID: 30737962
[TBL] [Abstract][Full Text] [Related]
13. Anti-allergic inflammatory effect of vanillic acid through regulating thymic stromal lymphopoietin secretion from activated mast cells.
Jeong HJ; Nam SY; Kim HY; Jin MH; Kim MH; Roh SS; Kim HM
Nat Prod Res; 2018 Dec; 32(24):2945-2949. PubMed ID: 29034737
[TBL] [Abstract][Full Text] [Related]
14. RANKL down-regulates the mast cell proliferation through inducing senescence.
Lim JH; Kim HY; Kang HG; Jeong HJ; Kim HM
Cytokine; 2022 Nov; 159():156018. PubMed ID: 36054965
[TBL] [Abstract][Full Text] [Related]
15. Naringenin suppresses the production of thymic stromal lymphopoietin through the blockade of RIP2 and caspase-1 signal cascade in mast cells.
Moon PD; Choi IH; Kim HM
Eur J Pharmacol; 2011 Dec; 671(1-3):128-32. PubMed ID: 21963452
[TBL] [Abstract][Full Text] [Related]
16. Epigallocatechin-3-gallate inhibits secretion of TNF-alpha, IL-6 and IL-8 through the attenuation of ERK and NF-kappaB in HMC-1 cells.
Shin HY; Kim SH; Jeong HJ; Kim SY; Shin TY; Um JY; Hong SH; Kim HM
Int Arch Allergy Immunol; 2007; 142(4):335-44. PubMed ID: 17135765
[TBL] [Abstract][Full Text] [Related]
17. Anti-inflammatory and anti-oxidative effects of the green tea polyphenol epigallocatechin gallate in human corneal epithelial cells.
Cavet ME; Harrington KL; Vollmer TR; Ward KW; Zhang JZ
Mol Vis; 2011 Feb; 17():533-42. PubMed ID: 21364905
[TBL] [Abstract][Full Text] [Related]
18. Epigallocatechin-3-gallate suppresses NF-kappaB activation and phosphorylation of p38 MAPK and JNK in human astrocytoma U373MG cells.
Kim SJ; Jeong HJ; Lee KM; Myung NY; An NH; Yang WM; Park SK; Lee HJ; Hong SH; Kim HM; Um JY
J Nutr Biochem; 2007 Sep; 18(9):587-96. PubMed ID: 17446059
[TBL] [Abstract][Full Text] [Related]
19. Molecular insights into the differences in anti-inflammatory activities of green tea catechins on IL-1β signaling in rheumatoid arthritis synovial fibroblasts.
Fechtner S; Singh A; Chourasia M; Ahmed S
Toxicol Appl Pharmacol; 2017 Aug; 329():112-120. PubMed ID: 28532672
[TBL] [Abstract][Full Text] [Related]
20. (-)-Epigallocatechin gallate amplifies interleukin-1-stimulated interleukin-6 synthesis in osteoblast-like MC3T3-E1 cells.
Kuroyanagi G; Otsuka T; Kondo A; Matsushima-Nishiwaki R; Mizutani J; Kozawa O; Tokuda H
Biochimie; 2013 Oct; 95(10):1933-8. PubMed ID: 23851196
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
